Hermann M. Wolf

2.8k total citations
82 papers, 1.9k citations indexed

About

Hermann M. Wolf is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Hermann M. Wolf has authored 82 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 21 papers in Genetics and 16 papers in Epidemiology. Recurrent topics in Hermann M. Wolf's work include Immunodeficiency and Autoimmune Disorders (29 papers), Immune Cell Function and Interaction (27 papers) and Blood disorders and treatments (13 papers). Hermann M. Wolf is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (29 papers), Immune Cell Function and Interaction (27 papers) and Blood disorders and treatments (13 papers). Hermann M. Wolf collaborates with scholars based in Austria, United States and Croatia. Hermann M. Wolf's co-authors include Martha M. Eibl, Aysen Samstag, Roberta Franceschini, Alessandro Moretta, Roberto Biassoni, Cristina Bottino, Luigi D. Notarangelo, J Y Bonnefoy, Michela Falco and Silvia Giliani and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Hermann M. Wolf

79 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann M. Wolf Austria 23 1.1k 323 271 268 235 82 1.9k
A J Cant United Kingdom 23 510 0.5× 315 1.0× 203 0.7× 186 0.7× 248 1.1× 57 1.5k
Gavin P Spickett United Kingdom 23 1.2k 1.1× 401 1.2× 222 0.8× 312 1.2× 199 0.8× 57 2.0k
B. Teisner Denmark 31 766 0.7× 226 0.7× 299 1.1× 279 1.0× 433 1.8× 136 2.8k
R J Levinsky United Kingdom 30 1.5k 1.4× 507 1.6× 269 1.0× 518 1.9× 283 1.2× 90 3.0k
Dominique De Wit Belgium 19 1.5k 1.4× 385 1.2× 185 0.7× 116 0.4× 143 0.6× 33 2.0k
Nikolaus Neu Austria 23 1.1k 1.0× 427 1.3× 189 0.7× 221 0.8× 114 0.5× 55 2.5k
Claire-Anne Siegrist Switzerland 14 1.5k 1.4× 724 2.2× 501 1.8× 171 0.6× 101 0.4× 17 2.7k
Maria Manuela Rosado Italy 25 1.4k 1.3× 386 1.2× 268 1.0× 249 0.9× 177 0.8× 57 2.6k
Eduardo Fernández‐Cruz Spain 30 1.3k 1.2× 557 1.7× 417 1.5× 179 0.7× 305 1.3× 121 2.5k
Nima Parvaneh Iran 26 1.4k 1.3× 389 1.2× 296 1.1× 593 2.2× 321 1.4× 132 2.1k

Countries citing papers authored by Hermann M. Wolf

Since Specialization
Citations

This map shows the geographic impact of Hermann M. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann M. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann M. Wolf more than expected).

Fields of papers citing papers by Hermann M. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann M. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann M. Wolf. The network helps show where Hermann M. Wolf may publish in the future.

Co-authorship network of co-authors of Hermann M. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann M. Wolf. A scholar is included among the top collaborators of Hermann M. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann M. Wolf. Hermann M. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geier, Christoph B., Svetlana Sharapova, Robert Gruber, et al.. (2024). Impaired B-cell function in ERCC2 deficiency. Frontiers in Immunology. 15. 1423141–1423141.
2.
Cinetto, Francesco, Klaus Fenchel, Riccardo Scarpa, et al.. (2023). Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review. Expert Review of Hematology. 16(4). 237–243. 1 indexed citations
3.
Geier, Christoph B., Peter Illéš, Michael B. Fischer, et al.. (2022). Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination. Frontiers in Immunology. 13. 827048–827048. 14 indexed citations
4.
Geier, Christoph B., Jocelyn R. Farmer, Zsófia Földvári, et al.. (2019). Vasculitis as a major morbidity factor in patients with hypomorphic RAG mutations. Journal of Allergy and Clinical Immunology. 143(2). AB116–AB116. 2 indexed citations
5.
Geier, Christoph B., et al.. (2017). Terminal 14q32.33 deletion as a novel cause of agammaglobulinemia. Clinical Immunology. 183. 41–45. 3 indexed citations
6.
Geier, Christoph B., et al.. (2015). Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens. PLoS ONE. 10(7). e0133220–e0133220. 30 indexed citations
7.
Stöllberger, Claudia, et al.. (2014). Dabigatran-induced lupus temporarily preventing blood group determination. Blood Coagulation & Fibrinolysis. 25(6). 625–627. 3 indexed citations
8.
Eibl, Martha M., et al.. (2006). Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia. Molecular Immunology. 44(7). 1639–1643. 14 indexed citations
9.
Eibl, N, Hermann M. Wolf, Gottfried Fischer, et al.. (2003). Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cellular Immunology. 221(1). 15–26. 62 indexed citations
10.
Thon, Vojtěch, et al.. (2002). Double mutant and formaldehyde inactivated TSST-1 as vaccinecandidates. Vaccine. 20. 1 indexed citations
11.
Wolf, Hermann M., et al.. (2001). Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.. PubMed. 21(4B). 2995–3000. 15 indexed citations
12.
Parolini, Silvia, Cristina Bottino, Michela Falco, et al.. (2000). X-Linked Lymphoproliferative Disease. The Journal of Experimental Medicine. 192(3). 337–346. 398 indexed citations
13.
Krainer, Michael, Hermann M. Wolf, Christoph Wiltschke, et al.. (2000). Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy. Urology. 55(6). 934–938. 3 indexed citations
14.
Eibl, Martha M. & Hermann M. Wolf. (1998). Biologic Consequences of Defective Major Histocompatibility Complex Class II Presentation. Current topics in microbiology and immunology. 232. 217–240. 1 indexed citations
15.
Bohuslavizki, K. H., et al.. (1995). Value of quantitative salivary gland scintigraphy in the early stage of Sjörgenʼs syndrome. Nuclear Medicine Communications. 16(11). 917–922. 37 indexed citations
16.
Rosén, Harald, et al.. (1992). Determination of placental ferritin (PLF)‐positive lymphocytes in women in early stages of breast cancer. International Journal of Cancer. 52(2). 229–233. 6 indexed citations
17.
Wolf, Hermann M. & Martha M. Eibl. (1991). The Relevance of Immunoglobulin in the Prevention of Necrotizing Enterocolitis. Advances in experimental medicine and biology. 310. 381–389. 6 indexed citations
18.
Müller, Christian, et al.. (1991). Helper-Inducer and Suppressor-Inducer Lymphocyte Subsets in Alcoholic Cirrhosis. Scandinavian Journal of Gastroenterology. 26(3). 295–301. 19 indexed citations
19.
Zielinski, C. C., P. Sevelda, E. Kubista, et al.. (1988). Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunology Immunotherapy. 27(3). 278–82. 21 indexed citations
20.
Wolf, Hermann M., et al.. (1960). Zahnärztliche Mundchirurgie für Studierende der Zahnheilkunde. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A J Cant Breakdown of academic impact, for papers by Gavin P Spickett Breakdown of academic impact, for papers by B. Teisner Breakdown of academic impact, for papers by R J Levinsky Breakdown of academic impact, for papers by Dominique De Wit Breakdown of academic impact, for papers by Nikolaus Neu Breakdown of academic impact, for papers by Claire-Anne Siegrist Breakdown of academic impact, for papers by Maria Manuela Rosado Breakdown of academic impact, for papers by Eduardo Fernández‐Cruz Breakdown of academic impact, for papers by Nima Parvaneh
Rankless by CCL
2026